Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Infertility treatment...

    Infertility treatment like IVF, raises risk of pregnancy complications

    Written by Hina Zahid Published On 2019-02-05T09:00:49+05:30  |  Updated On 5 Feb 2019 9:00 AM IST
    Infertility treatment like IVF, raises risk of pregnancy complications

    According to new research, Infertility treatment like IVF raises the risk of pregnancy complications in women. Women who have undergone infertility treatment, such as in vitro fertilization, are more likely to experience severe pregnancy complications.The research findings have been published in CMAJ(Canadian Medical Association Journal).


    The most common pregnancy complications associated with Infertility treatment include severe postpartum haemorrhage, admission to the intensive care unit and sepsis.The background rate in Canada of any severe complication is approximately 10 to 15 for every 1000 births.


    "We found that the women who received infertility treatment, especially in vitro fertilization, were about 40% more likely to experience a severe pregnancy complication compared with women who gave birth without any treatment," says lead author Dr. Natalie Dayan, Research Institute of the McGill University Health Centre, Montréal, Quebec. "However, it is important to remember that the absolute number of women who develop these complications remains quite small, meaning that for most women who cannot conceive naturally, this treatment is a very safe and effective method of becoming pregnant and having a child."


    The background rate in Canada of any severe complication is approximately 10 to 15 for every 1000 births. Maternal deaths are even rarer, occurring in 10 or fewer per 100,000 births in Canada. During pregnancy, such complications are often sudden and difficult to predict. It is important to identify women who may be at risk for these "near miss" events so that worse outcomes, including death, may be averted.


    In Canada, 1 in 6 couples is affected by infertility and many turn to infertility treatment, with about 18,000 pregnancies occurring after treatments with assisted reproductive technology each year. Fertility experts in Ontario have generated data to not only evaluate the rate of success of these treatments, but also to conduct appropriate surveillance of the mother's health after treatment.


    Canadian researchers looked at data on 813 719 live births and stillbirths in Ontario hospitals between 2006 and 2012. They identified 11 546 women who conceived through infertility treatment and matched them with 47 553 women with similar characteristics who conceived without assistance. The women who conceive with infertility treatment are typically older, report higher incomes, are more often first-time mothers and carry multiple fetuses.


    A severe maternal morbidity event occurred in 30.8 per 1000 infertility-treated pregnancies and in 22.2 per 1000 untreated pregnancies. This higher risk was seen among recipients of in vitro fertilization, but not among recipients of other forms of infertility treatment, such as intrauterine insemination or ovulation induction with medication.


    The current study, like others before it, shows that maternal age greater than 40 years and being pregnant with twins or triplets are each linked with a higher rate of these complications.


    Infertility treatment is often given to older women, and multiple pregnancy is also more likely after infertility treatment. The authors note that "[w]hether specific components of treatment using in vitro fertilization, such as the dose of ovarian hyperstimulation or fresh versus frozen embryo transfer, worsen maternal health, or whether the increased risk is a reflection of those who require or choose in vitro fertilization, remains to be determined."


    However, the present study does suggest a small added risk from the treatment itself.


    Over the last number of years, there have been worthy efforts by the medical and scientific community to promote optimal maternal health before infertility treatment. In addition, fertility specialists now often choose to implant only one embryo per mother to avoid risks associated with multiple pregnancies.


    This study will promote further in-depth research to understand how such infertility treatment protocols may be further modified to minimize these rare but important health risks and increase the chances of a successful and safe pregnancy for the mother and her child.


    For more details click on the link: http://dx.doi.org/10.1503/cmaj.181124
    Canadian Medical Association JournalCMAJDr Natalie DayanInfertility treatmentintensive care unitpostpartum hemorrhagepregnancy complicationssepsissevere postpartum hemorrhagevitro fertilization

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Hina Zahid
    Hina Zahid
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok